Literature DB >> 7741299

Halothane reduces focal ischemic injury in the rat when brain temperature is controlled.

D S Warner1, P S Ludwig, R Pearlstein, A D Brinkhous.   

Abstract

BACKGROUND: Previous work has demonstrated that rats anesthetized with halothane during focal cerebral ischemia have better histologic and neurologic outcome than do rats undergoing the same insult when awake. The purpose of this experiment was to determine whether this difference persists when brain temperature is held similar in halothane-anesthetized and awake experimental groups.
METHODS: Two ischemia experiments were performed. In both, the middle cerebral artery was occluded for 90 min. Temperature was monitored from a radiotelemetered thermistor implanted in the cerebral cortex. Four days after ischemia, infarct volume and neurologic function were assessed. In experiment 1, brain temperature was not controlled in awake rats. Temperature in rats anesthetized with halothane, approximately 1 minimum alveolar concentration, was regulated by servomechanism by surface heating or cooling to replicate the temperature profiles generated by awake animals. To address methodologic issues regarding infarct volume analysis, a subset of nine rats was examined for the effect of the histologic staining technique and the mathematical modeling algorithms used for computation of infarct volume values. In experiment 2, the brain temperature of awake and halothane-anesthetized rats was maintained normothermic (38.0 degrees C) throughout ischemia and early recirculation.
RESULTS: In experiment 1 no difference between groups was observed for cortical (halothane 146 +/- 95 mm3 and awake 126 +/- 108 mm3; P = 0.64) or subcortical (halothane 110 +/- 48 mm3 and awake 100 +/- 66 mm3; P = 0.66) infarct volume. Neurologic function was also similar between groups. Total infarct volume was approximately 11% greater when histologic sections were stained with hematoxylin and eosin than when they were stained with nitro blue tetrazolium, although volumes correlated closely between the two techniques (r2 = 0.996). Analysis by orthogonal or frustum projection from two-dimensional planimetric areas to three-dimensional volumes resulted in nearly identical values (r2 = 0.999). In experiment 2, halothane-anesthetized rats experienced a 46% reduction in cortical infarct volume (halothane 106 +/- 97 mm3 and awake 197 +/- 103 mm3; P = 0.03). The incidence of hemiparesis was reduced in the anesthetized group (P = 0.03).
CONCLUSIONS: When brain temperature was maintained normothermic throughout the focal ischemic insult, a neurologic and histologic protective effect for halothane anesthesia was observed. This effect of halothane was not sufficient to persist when large variations in brain temperature were allowed. Regulation of brain temperature is a critical factor in the determination of the effects of anesthetics on focal ischemic brain damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7741299     DOI: 10.1097/00000542-199505000-00019

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  15 in total

1.  Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies.

Authors:  Kenneth Sicard; Qiang Shen; Mathew E Brevard; Ross Sullivan; Craig F Ferris; Jean A King; Timothy Q Duong
Journal:  J Cereb Blood Flow Metab       Date:  2003-04       Impact factor: 6.200

Review 2.  Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors:  Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-18       Impact factor: 6.200

3.  Long-term neuroprotection from a potent redox-modulating metalloporphyrin in the rat.

Authors:  Huaxin Sheng; Wei Yang; Shiro Fukuda; Hubert M Tse; Wulf Paschen; Kwame Johnson; Ines Batinic-Haberle; James D Crapo; Robert D Pearlstein; Jon Piganelli; David S Warner
Journal:  Free Radic Biol Med       Date:  2009-07-22       Impact factor: 7.376

4.  Effect of halothane in cortical cell cultures exposed to N-methyl-D-aspartate.

Authors:  J P Beirne; R D Pearlstein; G W Massey; D S Warner
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

5.  Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage.

Authors:  Huaxin Sheng; Ivan Spasojevic; Hubert M Tse; Jin Yong Jung; Jun Hong; Zhiquan Zhang; Jon D Piganelli; Ines Batinic-Haberle; David S Warner
Journal:  J Pharmacol Exp Ther       Date:  2011-06-07       Impact factor: 4.030

Review 6.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

7.  Global ischemia-induced increases in the gap junctional proteins connexin 32 (Cx32) and Cx36 in hippocampus and enhanced vulnerability of Cx32 knock-out mice.

Authors:  K Oguro; T Jover; H Tanaka; Y Lin; T Kojima; N Oguro; S Y Grooms; M V Bennett; R S Zukin
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

8.  Intrinsic neurons of fastigial nucleus mediate neurogenic neuroprotection against excitotoxic and ischemic neuronal injury in rat.

Authors:  S B Glickstein; E V Golanov; D J Reis
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

9.  Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome.

Authors:  Shuang Ma; Dongmei Chu; Litao Li; Jennifer A Creed; Yu-Mi Ryang; Huaxin Sheng; Wei Yang; David S Warner; Dennis A Turner; Ulrike Hoffmann
Journal:  Crit Care Med       Date:  2019-08       Impact factor: 7.598

10.  Gap junctions and Bystander Effects: Good Samaritans and executioners.

Authors:  David C Spray; Regina Hanstein; Sandra V Lopez-Quintero; Randy F Stout; Sylvia O Suadicani; Mia M Thi
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.